South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
British American Tobacco’s Rothmans unit said it previously considered withdrawing from South Korea’s vaping market, but its Vuse products remain on sale while it reassesses conditions after new nicotine regulations. BAT reported H1 2026 APMEA vape volume down 20.2% and revenue down 25.6%. Philip Morris International launched VEEV inPRIME in June, expanding to about 14,000 stores from July.
How this was made
The 30-second read
Why it matters
BAT reframes its South Korea position as ongoing evaluation rather than a completed exit, while PMI proceeds with a scaled VEEV inPRIME rollout. Together, the moves suggest a near-term competitive re-rating risk for compliant vape brands in South Korea.
Market read
Traders get a concrete BAT versus PMI divergence in South Korea vape strategy tied to regulatory change, plus H1 APMEA vaping declines for BAT.
What to watch
The article does not quantify market share, pricing, or unit economics in South Korea, so traders may overestimate near-term financial impact from distribution expansion alone.
Background
South Korea introduced new nicotine regulations that affect synthetic nicotine and the competitive landscape for regulated vaping products versus illegal/unregulated offerings.
Ticker impact
PMI launched VEEV inPRIME in South Korea, expanding distribution to about 14,000 convenience stores and other channels from July.
Potentially supportive for PM’s smoke-free growth narrative, though magnitude depends on uptake and regulatory enforcement.
The article includes specific launch timing, device/pod platform details, and retail distribution scale, which are actionable for competitive positioning.
Market effects
Highlights how nicotine regulation and enforcement can reallocate resources between compliant vaping brands and illegal-market competition.
South Korea becomes a focal point for smoke-free category investment decisions as distribution scale and regulatory interpretation diverge.
Signals a broader multinational playbook shift for vape portfolios under tightening nicotine frameworks.
Counterpoint
BAT’s “reassessment” may still end in a withdrawal later; PMI’s rollout could face slower-than-expected adoption if enforcement or tax treatment changes.
Key entities
- companyBritish American Tobacco (BAT)
Rothmans unit reassessing South Korea vaping after new nicotine regulation; Vuse remains on sale through existing channels.
- companyPhilip Morris International (PMI)
Korean business launched VEEV inPRIME in June 2026 and expanded distribution to about 14,000 convenience stores and other channels from July.
- productVEEV inPRIME
PMI’s rechargeable closed-pod e-vapor system using the AdvanceVape Induction System.
- productVuse
BAT’s vaping brand referenced as remaining available through existing distribution channels in South Korea.
